This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1998 Dec;30(8):4087-9.

doi: 10.1016/s0041-1345(98)01351-7.

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

N Basara¹, W I Blau, M G Kiehl, E Römer, M Rudolphi, M Bischoff, D Kirsten, H Sanchez, S Günzelmann, A A Fauser

Affiliations

PMID: 9865306
DOI: 10.1016/s0041-1345(98)01351-7

Clinical Trial

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

N Basara et al. Transplant Proc. 1998 Dec.

. 1998 Dec;30(8):4087-9.

doi: 10.1016/s0041-1345(98)01351-7.

Authors

N Basara¹, W I Blau, M G Kiehl, E Römer, M Rudolphi, M Bischoff, D Kirsten, H Sanchez, S Günzelmann, A A Fauser

Affiliation

¹ Clinic for Bone Marrow Transplantation and Hematology/Oncology, Idar-Oberstein, Germany.

PMID: 9865306
DOI: 10.1016/s0041-1345(98)01351-7

No abstract available

PubMed Disclaimer

Similar articles

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Basara N, Kiehl MG, Blau W, Römer E, Bischoff M, Schmetzer B, Kirsten D, Günzelmann S, Fauser AA. Basara N, et al. Transplant Proc. 2001 May;33(3):2121-3. doi: 10.1016/s0041-1345(01)01968-6. Transplant Proc. 2001. PMID: 11377471 No abstract available.
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.
Basara N, Blau WI, Römer E, Rudolphi M, Bischoff M, Kirsten D, Sanchez H, Günzelmann S, Fauser AA. Basara N, et al. Bone Marrow Transplant. 1998 Jul;22(1):61-5. doi: 10.1038/sj.bmt.1701281. Bone Marrow Transplant. 1998. PMID: 9678797
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.
Basara N, Blau WI, Kiehl MG, Schmetzer B, Bischoff M, Kirsten D, Günzelmann S, Fauser AA. Basara N, et al. Clin Transplant. 2000 Apr;14(2):121-6. doi: 10.1034/j.1399-0012.2000.140204.x. Clin Transplant. 2000. PMID: 10770416 Clinical Trial.
New immunosuppressants in BMT/GVHD.
Basara N, Günzelmann S, Willenbacher W, Fauser AA, Kiehl MG. Basara N, et al. Transplant Proc. 2001 May;33(3):2220-2. doi: 10.1016/s0041-1345(01)01946-7. Transplant Proc. 2001. PMID: 11377507 Review. No abstract available.
Management of graft-versus-host disease.
Arai S, Vogelsang GB. Arai S, et al. Blood Rev. 2000 Dec;14(4):190-204. doi: 10.1054/blre.2000.0137. Blood Rev. 2000. PMID: 11124107 Review.

See all similar articles

Cited by

Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan.
Iida M, Fukuda T, Ikegame K, Yoshihara S, Ogawa H, Taniguchi S, Takami A, Abe Y, Hino M, Etou T, Ueda Y, Yujiri T, Matsui T, Okamura A, Tanaka J, Atsuta Y, Kodera Y, Suzuki R. Iida M, et al. Int J Hematol. 2011 Apr;93(4):523-531. doi: 10.1007/s12185-011-0817-8. Epub 2011 Apr 5. Int J Hematol. 2011. PMID: 21465117
Management of acute graft-versus-host disease in children.
Carpenter PA, Macmillan ML. Carpenter PA, et al. Pediatr Clin North Am. 2010 Feb;57(1):273-95. doi: 10.1016/j.pcl.2009.11.007. Pediatr Clin North Am. 2010. PMID: 20307721 Free PMC article. Review.
Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.
Kawashima N, Iida M, Suzuki R, Fukuda T, Atsuta Y, Hashii Y, Inoue M, Kobayashi M, Yabe H, Okada K, Adachi S, Yuza Y, Kawa K, Kato K. Kawashima N, et al. Int J Hematol. 2019 Apr;109(4):491-498. doi: 10.1007/s12185-019-02601-5. Epub 2019 Jan 29. Int J Hematol. 2019. PMID: 30694451 Clinical Trial.
A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease.
Onishi C, Ohashi K, Sawada T, Nakano M, Kobayashi T, Yamashita T, Akiyama H, Sakamaki H. Onishi C, et al. Int J Hematol. 2010 Apr;91(3):464-70. doi: 10.1007/s12185-010-0516-x. Epub 2010 Mar 10. Int J Hematol. 2010. PMID: 20217287
Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Chen X, Wang C, Yin J, Xu J, Wei J, Zhang Y. Chen X, et al. PLoS One. 2015 Aug 31;10(8):e0136991. doi: 10.1371/journal.pone.0136991. eCollection 2015. PLoS One. 2015. PMID: 26323092 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information